Sept 21 (Reuters) - Pfizer ( PFE ) is closing in on a
potential $7.3 billion takeover of anti-obesity drug developer
Metsera ( MTSR ), the Financial Times reported on Sunday, citing
unidentified sources.
Reuters could not immediately confirm the report.